Product Information
DICLOFENAC POT 50 MG TABLET is a generic product labeled by Amici Pharma, Inc, priced at $0.1125 per EA under NDC 69292055201. Its NADAC has been published 89 times since Jan 22, 2025.
FDA first approved this application on Mar 15, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Amici Pharma, IncNDC
69292055201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA215787FDA Approved
3/15/2023
TE Code
AB
On Market Since
3/12/2024
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC POT 50 MG TABLET has been published 89 times since Jan 22, 2025, and over the history we have for it it has risen 3.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1125 per EA |
|---|---|
| All-time high | $0.1422 (Aug 13, 2025) |
| All-time low | $0.0982 (Jul 22, 2026) |
| 52-week high | $0.1336 |
| 52-week low | $0.0982 |
| Median price | $0.1125 |
| Average price | $0.1168 |
| Largest weekly change | +10.8% (Mar 19, 2025) |
| Weeks tracked | 89 |
| Tracking since | Jan 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the diclofenac potassium, film coated market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amici Pharma, Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diclofenac potassium, film coated market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC POT 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC POT 50 MG TABLET, manufactured by Amici Pharma, Inc, is $0.1125 per EA (NDC 69292055201), effective Sep 30, 2026.
How has the price of DICLOFENAC POT 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for DICLOFENAC POT 50 MG TABLET has risen 3.1%. It has been tracked across 89 weekly CMS publications since Jan 22, 2025.
What are the highest and lowest recorded NADAC prices for DICLOFENAC POT 50 MG TABLET?
Since Jan 22, 2025, the NADAC for DICLOFENAC POT 50 MG TABLET has ranged from a low of $0.0982 (Jul 22, 2026) to a high of $0.1422 (Aug 13, 2025), with a median of $0.1125 per EA.
Are there cheaper alternatives to DICLOFENAC POT 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DICLOFENAC POT 50 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DICLOFENAC POT 50 MG TABLET?
DICLOFENAC POT 50 MG TABLET (NDC 69292055201) is labeled by Amici Pharma, Inc, and CMS classifies it as a generic product.